Relypsa - Articles and news items


FDA approves Veltassa following updated label warning regarding drug-drug interactions

Industry news / 5 December 2016 / Niamh Louise Marriott, Digital Editor

The updated US label for Veltassa recommends patients take Veltassa at least 3 hours before or 3 hours after other oral medications…

Vifor Pharma to top cardio-renal care after Galenica completes Relyapsa acquisition

Industry news / 6 September 2016 / Niamh Louise Marriott, Digital Content Producer

The combination of Galenica’s Vifor Pharma business with Relypsa will create a significant player in cardio-renal care in the US and further strength…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...